Soluble interleukin-2 receptor in Crohn's disease: relation of serum concentrations to disease activity.
- 1 September 1990
- Vol. 31 (9), 1033-1036
- https://doi.org/10.1136/gut.31.9.1033
Abstract
Serum concentrations of soluble interleukin-2 receptor (sIL-2R) were measured as a marker of immune activation in a group of 30 patients with Crohn's disease. sIL-2R concentrations were determined by enzyme linked immunosorbent assay during periods of active and inactive disease and correlated with standard parameters of disease activity. Serum concentrations of sIL-2R were significantly raised in patients with active Crohn's disease compared with patients with inactive disease (p less than 0.001) and control subjects. There was a significant correlation between serum sIL-2R concentrations and disease activity as assessed by the Harvey-Bradshaw index (r = 0.42, p less than 0.01), platelet numbers (r = 0.49, p less than 0.01), and orosomucoid (r = 0.47, p less than 0.01), alpha 1 antitrypsin (r = 0.44, p less than 0.01), and C reactive protein concentrations (r = 0.48, p less than 0.001) but not with the erythrocyte sedimentation rate. Measurement of serum sIL-2R concentration is a simple and useful laboratory means of assessing disease activity. Raised concentrations in patients with active Crohn's disease is further evidence for in vivo immune activation occurring in this disease.Keywords
This publication has 29 references indexed in Scilit:
- Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease.Gut, 1989
- Soluble interleukin 2 receptor in atopic eczema.BMJ, 1989
- Serum interleukin-2-receptor in rheumatoid arthritis: A prognostic indicator of disease activity?Journal of Autoimmunity, 1988
- Interleukin 6, the third mediator of acute‐phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1 β and tumor necrosis factor‐αEuropean Journal of Immunology, 1988
- Action of recombinant human interleukin 6, interleukin 1β and tumor necrosis factor α on the mRNA induction of acute‐phase proteinsEuropean Journal of Immunology, 1988
- The interleukin 2 receptor. Functional consequences of its bimolecular structure.The Journal of Experimental Medicine, 1987
- Expression of interleukin 2 receptors on activated human B cells.The Journal of Experimental Medicine, 1984
- Intestinal lymphocyte subpopulations in inflammatory bowel disease: an analysis by immunohistological and cell isolation techniques.Gut, 1984
- Why study T cell subsets in Crohn's disease?Gut, 1983
- A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITYThe Lancet, 1980